RheoSense Funding: How Much Did They Raise & Key Investors

How Much Did RheoSense Raise?
Funding & Key Investors

RheoSense, a prominent Silicon Valley-based high-tech firm, has successfully secured significant capital to bolster its market position in the precision measurement sector. With a cumulative capital infusion reaching $780K, the organization recently finalized a major strategic investment totaling $430K. This latest injection of financing underscores the company's robust growth trajectory and its critical role in providing essential analytical tools for global research and industrial applications.

The firm's ability to attract substantial backing reflects its established reputation as a leader in the development of advanced viscometry and rheology solutions. By leveraging its proprietary technology, RheoSense continues to set industry benchmarks, ensuring that its financial health remains aligned with its ambitious research and development objectives.

What is RheoSense?

RheoSense

Manufacturing

Test & Measurement Equipment

RheoSense operates at the intersection of biotechnology and microfluidics, specializing in the design and manufacture of high-precision instruments. Its core innovation, the patented Viscometer/Rheometer-on-a-Chip (VROC) technology, utilizes state-of-the-art MEMS (Micro-Electro-Mechanical Systems) to deliver unparalleled accuracy in fluid analysis. By offering the smallest sample volume requirements in the industry, the company has become an indispensable partner for Fortune Global 500 entities and premier academic institutions.

The company's market position is particularly strong within the protein therapeutics and pharmaceutical sectors, where precise viscosity measurement is vital for drug formulation and stability testing. Through its commitment to technical excellence and ease-of-use, RheoSense has effectively redefined the standards of the viscometry industry, transitioning from a niche innovator to a global enterprise-level provider.

How much funding has RheoSense raised?

RheoSense has raised a total of $780K across 2 funding rounds:

2020

Debt

$350K

2021

Debt

$430K

Debt (2020): $350K with participation from PPP

Debt (2021): $430K led by PPP

Key Investors in RheoSense

PPP

Public-Private Partnership

What's next for RheoSense?

With the recent influx of capital, RheoSense is well-positioned to accelerate its strategic expansion into emerging markets and further refine its microfluidics portfolio. The company is expected to prioritize the scaling of its manufacturing capabilities to meet the rising demand for protein therapeutics analysis. Furthermore, the strategic investment will likely facilitate deeper integration of its VROC technology into automated laboratory workflows, enhancing the efficiency of high-throughput screening processes.

As the company moves into its next phase of development, the focus will remain on maintaining its competitive edge through continuous innovation in MEMS-based instrumentation. By strengthening its global footprint and deepening its engagement with key pharmaceutical partners, RheoSense is poised to solidify its status as the definitive authority in fluid characterization and analytical precision.

See full RheoSense company page

See More Financial Insights